Published in Mol Microbiol on January 01, 2004
The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol (2006) 3.62
Discovery and characterization of sialic acid O-acetylation in group B Streptococcus. Proc Natl Acad Sci U S A (2004) 1.93
Prospects for vaccine prevention of meningococcal infection. Clin Microbiol Rev (2006) 1.53
Description and nomenclature of Neisseria meningitidis capsule locus. Emerg Infect Dis (2013) 1.47
Epidemiological profile of meningococcal disease in the United States. Clin Infect Dis (2010) 1.31
A generic mechanism in Neisseria meningitidis for enhanced resistance against bactericidal antibodies. J Exp Med (2008) 1.30
IS1301 fingerprint analysis of Neisseria meningitidis strains belonging to the ET-15 clone. J Clin Microbiol (2006) 1.16
Escherichia coli K1 polysialic acid O-acetyltransferase gene, neuO, and the mechanism of capsule form variation involving a mobile contingency locus. Proc Natl Acad Sci U S A (2005) 1.09
NeuA sialic acid O-acetylesterase activity modulates O-acetylation of capsular polysaccharide in group B Streptococcus. J Biol Chem (2007) 1.06
Evidence for capsule switching between carried and disease-causing Neisseria meningitidis strains. Infect Immun (2009) 1.05
Phosphoethanolamine residues on the lipid A moiety of Neisseria gonorrhoeae lipooligosaccharide modulate binding of complement inhibitors and resistance to complement killing. Infect Immun (2012) 1.05
Mechanisms in Neisseria meningitidis for resistance against complement-mediated killing. Vaccine (2008) 1.01
Analysis of human serum immunoglobulin G against O-acetyl-positive and O-acetyl-negative serogroup W135 meningococcal capsular polysaccharide. Clin Diagn Lab Immunol (2005) 0.94
Meningococcal group W-135 and Y capsular polysaccharides paradoxically enhance activation of the alternative pathway of complement. J Biol Chem (2011) 0.88
Molecular characterization of invasive Neisseria meningitidis strains isolated in Chile during 2010-2011. PLoS One (2013) 0.88
Vaccine development against Neisseria meningitidis. Microb Biotechnol (2011) 0.87
Inhibition of the alternative pathway of nonhuman infant complement by porin B2 contributes to virulence of Neisseria meningitidis in the infant rat model. Infect Immun (2014) 0.86
Biofilm formation by the human pathogen Neisseria meningitidis. Med Microbiol Immunol (2010) 0.85
Comparison of Phenotypic and Genotypic Approaches to Capsule Typing of Neisseria meningitidis by Use of Invasive and Carriage Isolate Collections. J Clin Microbiol (2015) 0.84
Virulence determinants involved in differential host niche adaptation of Neisseria meningitidis and Neisseria gonorrhoeae. Med Microbiol Immunol (2010) 0.84
The transcriptional repressor FarR is not involved in meningococcal fatty acid resistance mediated by the FarAB efflux pump and dependent on lipopolysaccharide structure. Appl Environ Microbiol (2010) 0.82
Crystal structure analysis of the polysialic acid specific O-acetyltransferase NeuO. PLoS One (2011) 0.80
Structural and kinetic characterizations of the polysialic acid O-acetyltransferase OatWY from Neisseria meningitidis. J Biol Chem (2009) 0.80
Inhibition of the classical pathway of complement by meningococcal capsular polysaccharides. J Immunol (2014) 0.80
Assays of sialate-O-acetyltransferases and sialate-O-acetylesterases. Glycoconj J (2009) 0.77
How the Knowledge of Interactions between Meningococcus and the Human Immune System Has Been Used to Prepare Effective Neisseria meningitidis Vaccines. J Immunol Res (2015) 0.77
Isolation and properties of two sialate-O-acetylesterases from horse liver with 4- and 9-O-acetyl specificities. Glycoconj J (2008) 0.76
Serogroup-specific interaction of Neisseria meningitidis capsular polysaccharide with host cell microtubules and effects on tubulin polymerization. Infect Immun (2013) 0.76
Regulation of capsule in Neisseria meningitidis. Crit Rev Microbiol (2015) 0.76
Specific synthesis of neurostatin and gangliosides O-acetylated in the outer sialic acids using a sialate transferase. PLoS One (2012) 0.75
Factors contributing to the immunogenicity of meningococcal conjugate vaccines. Hum Vaccin Immunother (2016) 0.75
High-throughput sequencing provides insights into genome variation and evolution in Salmonella Typhi. Nat Genet (2008) 19.97
Typing of methicillin-resistant Staphylococcus aureus in a university hospital setting by using novel software for spa repeat determination and database management. J Clin Microbiol (2003) 14.80
Sex and virulence in Escherichia coli: an evolutionary perspective. Mol Microbiol (2006) 14.53
Traces of human migrations in Helicobacter pylori populations. Science (2003) 11.92
Comparative analysis of the genome sequences of Bordetella pertussis, Bordetella parapertussis and Bordetella bronchiseptica. Nat Genet (2003) 9.13
Microevolution and history of the plague bacillus, Yersinia pestis. Proc Natl Acad Sci U S A (2004) 5.04
Evolutionary history of Salmonella typhi. Science (2006) 5.00
Salmonella typhi, the causative agent of typhoid fever, is approximately 50,000 years old. Infect Genet Evol (2002) 4.96
Who ate whom? Adaptive Helicobacter genomic changes that accompanied a host jump from early humans to large felines. PLoS Genet (2006) 4.65
Yersinia pestis genome sequencing identifies patterns of global phylogenetic diversity. Nat Genet (2010) 4.35
Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. Genome Res (2009) 3.99
The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol (2006) 3.62
Frequent emergence and limited geographic dispersal of methicillin-resistant Staphylococcus aureus. Proc Natl Acad Sci U S A (2008) 3.52
The peopling of the Pacific from a bacterial perspective. Science (2009) 3.14
Predicted strain coverage of a meningococcal multicomponent vaccine (4CMenB) in Europe: a qualitative and quantitative assessment. Lancet Infect Dis (2013) 2.95
Validation of serological correlate of protection for meningococcal C conjugate vaccine by using efficacy estimates from postlicensure surveillance in England. Clin Diagn Lab Immunol (2003) 2.91
Distinguishing human ethnic groups by means of sequences from Helicobacter pylori: lessons from Ladakh. Proc Natl Acad Sci U S A (2004) 2.83
Immunogenicity and safety of a meningococcal A conjugate vaccine in Africans. N Engl J Med (2011) 2.72
Cardiovascular safety of tiotropium in patients with COPD. Chest (2009) 2.70
A bimodal pattern of relatedness between the Salmonella Paratyphi A and Typhi genomes: convergence or divergence by homologous recombination? Genome Res (2006) 2.62
The complete genome sequence of the carcinogenic bacterium Helicobacter hepaticus. Proc Natl Acad Sci U S A (2003) 2.62
Gain and loss of multiple genes during the evolution of Helicobacter pylori. PLoS Genet (2005) 2.61
A genomic portrait of the emergence, evolution, and global spread of a methicillin-resistant Staphylococcus aureus pandemic. Genome Res (2013) 2.59
Distinct clones of Yersinia pestis caused the black death. PLoS Pathog (2010) 2.48
Meningococcal genetic variation mechanisms viewed through comparative analysis of serogroup C strain FAM18. PLoS Genet (2006) 2.47
Revaccination with measles, tetanus, poliovirus, Haemophilus influenzae type B, meningococcus C, and pneumococcus vaccines in children after hematopoietic stem cell transplantation. Clin Infect Dis (2007) 2.45
Prospective study of a serogroup X Neisseria meningitidis outbreak in northern Ghana. J Infect Dis (2002) 2.40
RIDOM: Ribosomal Differentiation of Medical Micro-organisms Database. Nucleic Acids Res (2002) 2.33
RIDOM: comprehensive and public sequence database for identification of Mycobacterium species. BMC Infect Dis (2003) 2.33
Multicenter, open-label, randomized phase II controlled trial of an investigational recombinant Meningococcal serogroup B vaccine with and without outer membrane vesicles, administered in infancy. Clin Infect Dis (2010) 2.24
Historical variations in mutation rate in an epidemic pathogen, Yersinia pestis. Proc Natl Acad Sci U S A (2012) 2.22
Many carried meningococci lack the genes required for capsule synthesis and transport. Microbiology (2002) 2.17
High-throughput genotyping of Salmonella enterica serovar Typhi allowing geographical assignment of haplotypes and pathotypes within an urban District of Jakarta, Indonesia. J Clin Microbiol (2008) 2.14
Genetic analysis of meningococci carried by children and young adults. J Infect Dis (2005) 2.12
Updated postlicensure surveillance of the meningococcal C conjugate vaccine in England and Wales: effectiveness, validation of serological correlates of protection, and modeling predictions of the duration of herd immunity. Clin Vaccine Immunol (2010) 2.11
Mismatch induced speciation in Salmonella: model and data. Philos Trans R Soc Lond B Biol Sci (2006) 2.11
Whole-genome comparison of disease and carriage strains provides insights into virulence evolution in Neisseria meningitidis. Proc Natl Acad Sci U S A (2008) 2.06
Advances in the development of vaccines against Neisseria meningitidis. N Engl J Med (2010) 1.99
Sequence diversity of the factor H binding protein vaccine candidate in epidemiologically relevant strains of serogroup B Neisseria meningitidis. J Infect Dis (2009) 1.92
Microevolution of Helicobacter pylori during prolonged infection of single hosts and within families. PLoS Genet (2010) 1.89
Safety, immunogenicity, and antibody persistence of a new meningococcal group A conjugate vaccine in healthy Indian adults. Vaccine (2007) 1.85
Parallel independent evolution of pathogenicity within the genus Yersinia. Proc Natl Acad Sci U S A (2014) 1.83
Molecular analysis of bacteria in periodontitis: evaluation of clone libraries, novel phylotypes and putative pathogens. Microbiology (2003) 1.83
The meningococcal vaccine candidate neisserial surface protein A (NspA) binds to factor H and enhances meningococcal resistance to complement. PLoS Pathog (2010) 1.81
Meningococcal C conjugate vaccine: the experience in England and Wales. Vaccine (2009) 1.79
Evolution and population structure of Salmonella enterica serovar Newport. J Bacteriol (2010) 1.79
Spatiotemporal analysis of invasive meningococcal disease, Germany. Emerg Infect Dis (2006) 1.78
Development and validation of a nonaplex assay for the simultaneous quantitation of antibodies to nine Streptococcus pneumoniae serotypes. J Immunol Methods (2004) 1.74
Immunogenicity of two investigational serogroup B meningococcal vaccines in the first year of life: a randomized comparative trial. Pediatr Infect Dis J (2010) 1.73
CRISPR typing and subtyping for improved laboratory surveillance of Salmonella infections. PLoS One (2012) 1.68
The rise and fall of epidemic Neisseria meningitidis serogroup W135 meningitis in Burkina Faso, 2002-2005. Clin Infect Dis (2006) 1.66
Invasive pneumococcal disease, comorbidities, and polysaccharide vaccine use in children aged 5-15 years in England and Wales. Clin Infect Dis (2013) 1.66
Multi locus sequence typing of Chlamydiales: clonal groupings within the obligate intracellular bacteria Chlamydia trachomatis. BMC Microbiol (2008) 1.65
Population structure of the Yersinia pseudotuberculosis complex according to multilocus sequence typing. Environ Microbiol (2011) 1.64
A global overview of the genetic and functional diversity in the Helicobacter pylori cag pathogenicity island. PLoS Genet (2010) 1.64
Age of the association between Helicobacter pylori and man. PLoS Pathog (2012) 1.62
A surveillance network for meningococcal disease in Europe. FEMS Microbiol Rev (2006) 1.62
Recombination and population structure in Salmonella enterica. PLoS Genet (2011) 1.61
Seroprevalence of meningococcal serogroup C bactericidal antibody in England and Wales in the pre-vaccination era. Vaccine (2003) 1.60
Genome sequence of the deep-rooted Yersinia pestis strain Angola reveals new insights into the evolution and pangenome of the plague bacterium. J Bacteriol (2010) 1.60
Evolution of bacteriophages infecting encapsulated bacteria: lessons from Escherichia coli K1-specific phages. Mol Microbiol (2006) 1.60
Development and evaluation of a tetraplex flow cytometric assay for quantitation of serum antibodies to Neisseria meningitidis serogroups A, C, Y, and W-135. Clin Diagn Lab Immunol (2004) 1.59
Added value of PCR-testing for confirmation of invasive meningococcal disease in England. J Infect (2013) 1.58
Immunogenicity and boosting after a reduced number of doses of a pneumococcal conjugate vaccine in infants and toddlers. Pediatr Infect Dis J (2006) 1.57
Clonal waves of Neisseria colonisation and disease in the African meningitis belt: eight- year longitudinal study in northern Ghana. PLoS Med (2007) 1.56
Interlaboratory comparison of PCR-based identification and genogrouping of Neisseria meningitidis. J Clin Microbiol (2005) 1.56
Neisserial lipooligosaccharide is a target for complement component C4b. Inner core phosphoethanolamine residues define C4b linkage specificity. J Biol Chem (2003) 1.55
Invasive meningococcal disease in England and Wales: implications for the introduction of new vaccines. Vaccine (2012) 1.54
Diagnostic potential of targeted electrical impedance scanning in classifying suspicious breast lesions. Invest Radiol (2002) 1.53
Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings. J Antimicrob Chemother (2011) 1.53
Clinical and immunologic risk factors for meningococcal C conjugate vaccine failure in the United Kingdom. J Infect Dis (2006) 1.52
Bactericidal antibody against a representative epidemiological meningococcal serogroup B panel confirms that MATS underestimates 4CMenB vaccine strain coverage. Vaccine (2013) 1.49
Neutral genomic microevolution of a recently emerged pathogen, Salmonella enterica serovar Agona. PLoS Genet (2013) 1.48
Horizontal versus familial transmission of Helicobacter pylori. PLoS Pathog (2008) 1.48
Description and nomenclature of Neisseria meningitidis capsule locus. Emerg Infect Dis (2013) 1.47
Effect of vaccination with carrier protein on response to meningococcal C conjugate vaccines and value of different immunoassays as predictors of protection. Infect Immun (2002) 1.46
Simultaneous adrenal and extra-adrenal myelolipoma - an uncommon incident: case report and review of the literature. World J Surg Oncol (2008) 1.46
Bactericidal antibody is the immunologic surrogate of protection against meningococcal disease. Vaccine (2009) 1.44
A prospective study of etiology of childhood acute bacterial meningitis, Turkey. Emerg Infect Dis (2008) 1.44
The rise and spread of a new pathogen: seroresistant Moraxella catarrhalis. Genome Res (2007) 1.40
Target gene sequencing to characterize the penicillin G susceptibility of Neisseria meningitidis. Antimicrob Agents Chemother (2007) 1.40
Deciphering host migrations and origins by means of their microbes. Mol Ecol (2005) 1.39
Antibody persistence in Australian adolescents following meningococcal C conjugate vaccination. Pediatr Infect Dis J (2015) 1.38
Binding of the complement inhibitor C4bp to serogroup B Neisseria meningitidis. J Immunol (2005) 1.38
Prevalence and antimicrobial susceptibility of microorganisms isolated from sputa of patients with cystic fibrosis. J Cyst Fibros (2007) 1.37